These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 33989991

  • 1. Hepatic metabolomics of the compatibility effect of Xiaoyaosan on CUMS-induced depression based on the TCM theory of "Treating Diseases via Regulating the Liver's Function".
    Liu XJ, Liu HL, Zhao D, Wei FX, Wang YZ, Lv M, Chen SJ, Li SY, Qin XM.
    J Pharm Biomed Anal; 2021 Jul 15; 201():114123. PubMed ID: 33989991
    [Abstract] [Full Text] [Related]

  • 2. Deciphering the compatibility rules of traditional Chinese medicine prescriptions based on NMR metabolomics: A case study of Xiaoyaosan.
    Liu X, Lv M, Wang Y, Zhao D, Zhao S, Li S, Qin X.
    J Ethnopharmacol; 2020 May 23; 254():112726. PubMed ID: 32135241
    [Abstract] [Full Text] [Related]

  • 3. Serum metabolomics reveals compatibility rules of the antidepressant effects of Xiaoyaosan and its efficacy groups.
    Liu X, Wang Y, Lv M, Zhao S, Chen S, Li S, Qin X.
    Psychiatry Res; 2021 May 23; 299():113827. PubMed ID: 33676173
    [Abstract] [Full Text] [Related]

  • 4. The synergistic anti-depression effects of different efficacy groups of Xiaoyaosan as demonstrated by the integration of network pharmacology and serum metabolomics.
    Liu XJ, Wang YZ, Wei FX, Lv M, Qu P, Chen SJ, Li SY, Qin X.
    J Pharm Biomed Anal; 2021 Apr 15; 197():113949. PubMed ID: 33618131
    [Abstract] [Full Text] [Related]

  • 5. Gut microbiome and tissue metabolomics reveal the compatibility effects of Xiaoyaosan on depression based on "gut-liver-kidney" axis.
    Liu X, Wu X, Wang S, Qin X.
    Phytomedicine; 2023 Mar 15; 111():154628. PubMed ID: 36731299
    [Abstract] [Full Text] [Related]

  • 6. Anti-depressive effects of Xiaoyaosan, Shugan and Jianpi herbal treatments: Role on the gut microbiome of CUMS rats.
    Liu X, Lv M, Wang Y, Qu P, Li S, Yu Z, Qin X.
    Phytomedicine; 2021 Jul 15; 87():153581. PubMed ID: 34091149
    [Abstract] [Full Text] [Related]

  • 7. Brain metabonomics study of the antidepressant-like effect of Xiaoyaosan on the CUMS-depression rats by 1H NMR analysis.
    Liu X, Zheng X, Du G, Li Z, Qin X.
    J Ethnopharmacol; 2019 May 10; 235():141-154. PubMed ID: 30708033
    [Abstract] [Full Text] [Related]

  • 8. A combination of cecum microbiome and metabolome in CUMS depressed rats reveals the antidepressant mechanism of traditional Chinese medicines: A case study of Xiaoyaosan.
    Lv M, Wang Y, Qu P, Li S, Yu Z, Qin X, Liu X.
    J Ethnopharmacol; 2021 Aug 10; 276():114167. PubMed ID: 33984458
    [Abstract] [Full Text] [Related]

  • 9. Studies on the potential link between antidepressant effect of Xiaoyao San and its pharmacological activity of hepatoprotection based on multi-platform metabolomics.
    Chen C, Yin Q, Tian J, Gao X, Qin X, Du G, Zhou Y.
    J Ethnopharmacol; 2020 Mar 01; 249():112432. PubMed ID: 31790818
    [Abstract] [Full Text] [Related]

  • 10. Metabonomic study on chronic unpredictable mild stress and intervention effects of Xiaoyaosan in rats using gas chromatography coupled with mass spectrometry.
    Gao X, Zheng X, Li Z, Zhou Y, Sun H, Zhang L, Guo X, Du G, Qin X.
    J Ethnopharmacol; 2011 Sep 01; 137(1):690-9. PubMed ID: 21718771
    [Abstract] [Full Text] [Related]

  • 11. Dynamic analysis of the endogenous metabolites in depressed patients treated with TCM formula Xiaoyaosan using urinary (1)H NMR-based metabolomics.
    Tian JS, Peng GJ, Gao XX, Zhou YZ, Xing J, Qin XM, Du GH.
    J Ethnopharmacol; 2014 Dec 02; 158 Pt A():1-10. PubMed ID: 25448502
    [Abstract] [Full Text] [Related]

  • 12. A unique insight for Xiaoyao San exerts antidepressant effects by modulating hippocampal glucose catabolism using stable isotope-resolved metabolomics.
    Wu WZ, Ling-Hu T, Zhao YH, Zhao WD, Ji C, Tian JS, Ren Y, Qin XM.
    J Ethnopharmacol; 2023 Jan 10; 300():115702. PubMed ID: 36099982
    [Abstract] [Full Text] [Related]

  • 13. Antidepressant-like effects of the fractions of Xiaoyaosan on rat model of chronic unpredictable mild stress.
    Zhou Y, Lu L, Li Z, Gao X, Tian J, Zhang L, Wu B, Qin X.
    J Ethnopharmacol; 2011 Sep 01; 137(1):236-44. PubMed ID: 21640181
    [Abstract] [Full Text] [Related]

  • 14. Xiaoyaosan exerts antidepressant-like effects by regulating the functions of astrocytes and EAATs in the prefrontal cortex of mice.
    Liu Y, Ding XF, Wang XX, Zou XJ, Li XJ, Liu YY, Li J, Qian XY, Chen JX.
    BMC Complement Altern Med; 2019 Aug 14; 19(1):215. PubMed ID: 31412844
    [Abstract] [Full Text] [Related]

  • 15. Integrating hippocampal metabolomics and network pharmacology deciphers the antidepressant mechanisms of Xiaoyaosan.
    Liu X, Wei F, Liu H, Zhao S, Du G, Qin X.
    J Ethnopharmacol; 2021 Mar 25; 268():113549. PubMed ID: 33152435
    [Abstract] [Full Text] [Related]

  • 16. Xiaoyaosan against depression through suppressing LPS mediated TLR4/NLRP3 signaling pathway in "microbiota-gut-brain" axis.
    Liu X, Liu H, Wu X, Zhao Z, Wang S, Wang H, Qin X.
    J Ethnopharmacol; 2024 Dec 05; 335():118683. PubMed ID: 39121928
    [Abstract] [Full Text] [Related]

  • 17. Plasma metabolomics of depressed patients and treatment with Xiaoyaosan based on mass spectrometry technique.
    Liu X, Liu C, Tian J, Gao X, Li K, Du G, Qin X.
    J Ethnopharmacol; 2020 Jan 10; 246():112219. PubMed ID: 31494201
    [Abstract] [Full Text] [Related]

  • 18. Xiaoyaosan promotes neurotransmitter transmission and alleviates CUMS-induced depression by regulating the expression of Oct1 and Oct3 in astrocytes of the prefrontal cortex.
    Wu Y, Liu L, Zhao Y, Li X, Hu J, Li H, Zhao R.
    J Ethnopharmacol; 2024 May 23; 326():117923. PubMed ID: 38367929
    [Abstract] [Full Text] [Related]

  • 19. Anti-depressant effects of Xiaoyaosan on rat model of chronic unpredictable mild stress: a plasma metabonomics study based on NMR spectroscopy.
    Liu XJ, Zhou YZ, Li ZF, Cui J, Li ZY, Gao XX, Sun HF, Zhang LZ, Du GH, Qin XM.
    J Pharm Pharmacol; 2012 Apr 23; 64(4):578-88. PubMed ID: 22420663
    [Abstract] [Full Text] [Related]

  • 20. A preliminary study on the diversity of butyrate-producing bacteria in response to the treatment of depression with Xiaoyaosan.
    Xiong LL, Mao ML, Shu QL.
    Lett Appl Microbiol; 2022 Oct 23; 75(4):844-856. PubMed ID: 35575477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.